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The ubiquitin ligase TRIM27 
functions as a host restriction factor 
antagonized by Mycobacterium 
tuberculosis PtpA during 
mycobacterial infection
Jing Wang1, Jade L. L. Teng2, Dongdong Zhao1,3, Pupu Ge1, Bingxi Li1, Patrick C. Y. Woo2 & 
Cui Hua Liu1,3
Macrophage-mediated innate immune responses play crucial roles in host defense against pathogens. 
Recent years have seen an explosion of host proteins that act as restriction factors blocking viral 
replication in infected cells. However, the essential factors restricting Mycobacterium tuberculosis 
(Mtb) and their regulatory roles during mycobacterial infection remain largely unknown. We previously 
reported that Mtb tyrosine phosphatase PtpA, a secreted effector protein required for intracellular 
survival of Mtb, inhibits innate immunity by co-opting the host ubiquitin system. Here, we identified 
a new PtpA-interacting host protein TRIM27, which is reported to possess a conserved RING domain 
and usually acts as an E3 ubiquitin ligase that interferes with various cellular processes. We further 
demonstrated that TRIM27 restricts survival of mycobacteria in macrophages by promoting innate 
immune responses and cell apoptosis. Interestingly, Mtb PtpA could antagonize TRIM27-promoted 
JNK/p38 MAPK pathway activation and cell apoptosis through competitively binding to the RING 
domain of TRIM27. TRIM27 probably works as a potential restriction factor for Mtb and its function 
is counteracted by Mtb effector proteins such as PtpA. Our study suggests a potential tuberculosis 
treatment via targeting of the TRIM27-PtpA interfaces.
The innate immunity is a universal and ancient form of host defense system against invading pathogens. During 
infection, a variety of receptors on/in macrophages called pattern recognition receptor (PRR) can recognize con-
served products of pathogens (pathogen-associated molecular patterns, PAMP) to stimulate certain host immune 
and inflammatory signaling pathways upon pathogen infection. Central to the innate immune signaling, the 
nuclear factor-κ B (NF-κ B) and JNK/p38 mitogen-activated protein kinase (MAPK) pathways are crucial in reg-
ulating cytokine production1,2 downstream of recognition of PAMPs.
Upon infection by pathogens, some host proteins, called restriction factors3, are stimulated to enhance host 
innate immune responses to suppress the intracellular survival of pathogens. In recent years, there has been an 
explosion in the investigation of host proteins that act as restriction factors to block the replication cycles of 
viruses4–9. The tripartite motif containing (TRIM) proteins are involved in a broad range of biological processes 
including cell proliferation, differentiation, development and apoptosis. The majority of TRIM family members 
possess a conserved RBCC motif, which consists of a RING domain and one or two B-Box domains followed by 
a coiled-coil region. Previous reports have shown that the TRIM protein family is emerging as a key component 
of host antiviral innate immunity10. Beginning with the identification of TRIM5α as a post-entry restriction 
factor against retroviruses, a lot of progress has been made on how TRIM proteins influence immunity over the 
past decade11,12, including the identification of TRIM56, which dictates antiviral restriction of influenza A and B 
viruses by impeding viral RNA synthesis13,14.
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In order to promote virulence and evade detection and immune clearance, bacterial pathogens have evolved 
various effector proteins to perturb host immune responses by targeting the key components of innate immune 
system. For example, Salmonella typhimurium expresses the kinase SteC, which phosphorylates MKK1/2, leading 
to activation of ERK1/2 and reorganization of the actin cytoskeleton, which restrains bacterial growth15; and 
Legionella pneumophila translocates LegK1 into macrophages to activate NF-κ B signaling pathway, which causes 
the inhibition of cell apoptosis and promotes the intracellular survival of bacteria2. Understanding the elaborate 
strategies that pathogens employ to subvert their host immune responses is helpful to identify novel approaches 
for prevention and treatment of infection.
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is one of the most dangerous 
infectious pathogens worldwide. In 2014, more than 9 million people were estimated as new TB cases and about 
1.5 million died from the disease15. As an intracellular pathogen, Mtb secretes a number of proteins into host 
macrophages to interfere with various cellular processes, such as apoptosis, autophagy and the signaling path-
ways13,16–18. Mtb PtpA is a secreted low-molecular weight tyrosine phosphatase required for intracellular survival 
of mycobacteria, and it also acts as a pivotal modulator of host innate immune responses14,18,19 and cell apoptosis20. 
We previously revealed that PtpA inhibits the innate immune signaling pathways and phagosome maturation 
by co-opting host ubiquitin via a previously unknown ubiquitin-interacting motif-like (UIML) region, which 
leads to the suppression of innate immunity16. In this work, we identified TRIM27 as a novel PtpA-interacting 
host protein. TRIM27 has been previously characterized as a transcription repressor through interaction with 
retinoblastoma-associate protein (Rb), Enhancer of the Polycomb 1 (EPC1), or Mi-2b-containing histone 
deacetylase complex in the nucleus21–24. Harboring a RING domain, TRIM27 has also been shown to be an E3 
ubiquitin ligase25–29 and to possess SUMO E3 ligase activity as well30. We further demonstrated that TRIM27 
restricts the intracellular survival of mycobacteria, suggesting that it is a potential host restriction factor for Mtb. 
Moreover, we showed that TRIM27 suppresses the intracellular survival of mycobacteria by enhancing host 
immune-inflammatory responses mediated by JNK/p38 pathways as well as cell apoptosis. Interestingly, Mtb 
PtpA antagonizes TRIM27-promoted JNK/p38 MAPK pathway activation and cell apoptosis through competi-
tively binding to the RING domain of TRIM27. Our findings highlight an evolutionary dynamics of interactions 
between a host restriction factor and its pathogen antagonist during mycobacterial infection.
Results
Identification of Mtb PtpA interacting host proteins. In our efforts to conduct more in-depth investi-
gation into the immune-regulatory mechanisms of Mtb PtpA, we identified another novel Mtb PtpA-interacting 
host protein TRIM27 through a yeast two-hybrid assay from a mouse cDNA library (Fig. 1a). Among all the can-
didate Mtb PtpA-interacting host proteins we identified, TRIM27 aroused our interest because many members 
of TRIM family have been shown to play crucial role in the process of pathogen defense10–12. We confirmed the 
interactions between Mtb PtpA and TRIM27 by co-immunoprecipitation in HEK293T cells cotransfected with 
vectors encoding PtpA and TRIM27 (Fig. 1b) and in U937 cells infected with BCG strains (Fig. 1c). We further 
showed that Mtb PtpA interacts with TRIM27 via the RING domain (Fig. 1d), a region defining the E3 ubiqui-
tin ligase activity of TRIM27. Deletion of RING domain disrupts the interactions between TRIM27 and PtpA 
(Supplementary Fig. 1). In addition, immunouorescence confocal microscopy analysis data indicated that the 
secreted protein PtpA, but not the bacterium itself, co-localized with TRIM27 in macrophage cells during myco-
bacterial infection (Fig. 1e). These results suggest that the Mtb PtpA-interacting TRIM27 may play an impor-
tant regulatory role during mycobacterial infection dependent on its E3 ubiquitin ligase activity, which could be 
potentially counteracted by the Mtb effector protein PtpA.
TRIM27 restricts the survival of mycobacteria in macrophages. To better understand the physio-
logical role of TRIM27 during mycobacterial infection, we then sought to examine whether TRIM27 regulates 
the intercellular survival of BCG or M. smegmatis, the widely used model organisms used for elucidating the 
pathogenesis of mycobacteria in macrophages. Macrophage-like U937 cells (differentiated from U937 human 
monocytic cells) were transfected with negative control small interfering RNA (NC siRNA) or TRIM27-specific 
siRNA, followed by infection with mycobacteria. Immunoblot analysis was performed to test the knockdown 
efficiency of siRNAs (Fig. 2a). The mycobacterial colony-forming units (CFUs) decreased from 2 h after infection 
of either BCG or M. smegmatis. Knock-down of TRIM27 significantly promoted the intercellular survival of BCG 
(Fig. 2b) and M. smegmatis (Fig. 2c) from 8 h post-infection of U937 cells. Different from M. smegmatis of which 
the CFUs decreased consistently, the CFUs of BCG increased after 24 h post-infection. In addition, infection 
of BCG (Fig. 2d) or M. smegmatis (Fig. 2e) induced expression of TRIM27 in U937 cells at 2 h post-infection, 
followed by decline at later time points. Controls with non-infected U937 cells and with latex beads at each time 
point were used to demonstrate the specificity of TRIM27 expression in response to mycobacterial infection. As a 
whole, these results indicate the possibility that TRIM27 might function as a host restriction factor being stimu-
lated upon the invasion of mycobacteria to suppress the intracellular survival of the pathogens.
TRIM27 promotes JNK and p38 pathway activation and suppresses NF-κB activation. Central 
to the innate immune system, the NF-κ B and JNK/p38 signaling pathways control inflammatory cytokine induc-
tion to defend against invading bacteria. To investigate the underlying mechanisms by which TRIM27 modulates 
innate immune responses, dual-luciferase reporter assay and immunoblot analysis were performed to examine the 
effects of TRIM27 on immune signaling pathways. The data revealed that knockdown of TRIM27 in U937 mac-
rophage cells efficiently blocked JNK/p38 signal pathway activation induced by BCG infection (Fig. 3a), whereas 
it promoted the BCG-stimulated NF-κ B activation in a RING domain-dependent manner (Fig. 3b). Consistently, 
overexpression of TRIM27 in HEK293T cells induced a significant activation of JNK/p38 MAPK pathways stim-
ulated by the constitutively active Rac mutant RacL61 and partially inhibited TNF-induced activation of NF-κ B 
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Figure 1. Identification of TRIM27 as a Mycobacterium tuberculosis (Mtb) PtpA-interacting host protein. 
(a) Mtb PtpA interacts with TRIM27 in the yeast two-hybrid assay. Yeast strains were transformed with 
indicated vectors in which TAK1 and TAB2 interaction served as a positive control. Left, high-stringency. Right, 
low-stringency. (b) Immunoblot analysis (IB) of proteins immunoprecipitated (IP) with immunoglobulin G 
(IgG; control), anti-Flag or anti-Myc from lysates of HEK293T cells transfected with vectors encoding Flag-
tagged PtpA and Myc-tagged TRIM27 (top), and immunoblot analysis without immunoprecipitation (Input; 
below). (c) Immunoblot analysis of proteins immunoprecipitated with anti-PtpA from lysates of U937 cells 
infected with wild-type (WT) BCG or PtpA deleted BCG (BCGΔ PtpA) for 24 h. Non-infected cells were 
used as a control. (d) Immunoblot analysis of proteins immunoprecipitated with anti-Myc from lysates of 
HEK293T cells transfected with vectors encoding Flag-tagged PtpA and Myc-tagged full-length (FL) TRIM27 
or its truncated forms (R, RING; BCC, B-Box region and coiled-coil region; RFP, RFP region). (e) Confocal 
microscopy of U937 cells infected with BCG at a MOI of 20. Mtb PtpA (Green) colocalizes with TRIM27 (Red) 
in U937 cells. Bacteria (Blue) were stained with Alexa 350 carboxylic acid succinimidyl eater. Scale bars, 10 μ m.
www.nature.com/scientificreports/
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pathway (Supplementary Fig. 2a,b), while had no effects on Erk pathway activation (Supplementary Fig. 2c). 
Thus, TRIM27 promotes JNK and p38 pathway activation and suppresses NF-κ B activation. It is noteworthy that 
the effects of TRIM27-mediated activation of JNK/p38 pathways and inhibition of NF-κ B pathway were more 
obvious during mycobacterial infection in the absence of PtpA (Fig. 3a,b), suggesting that PtpA might coun-
teract the function of the TRIM27. Since Mtb PtpA was reported to be a tyrosine phosphatase and a variety of 
host substrates have been identified14,16,20,31, we thus sought to determine whether TRIM27 is a substrate of Mtb 
PtpA, and our data from in vitro dephosphorylation assay suggested an opposite result (Supplementary Fig. 3). 
In addition, the PtpA phosphatase inactive mutant (D126A) was also able to interact with the RING domain of 
TRIM27 (Supplementary Fig. 4), and the BCG strain expressing the PtpA D126A mutant had the same antago-
nizing effects as the WT BCG (Fig. 3a,b).
To further investigate the effects of TRIM27 on regulating the NF-κ B and JNK/p38 pathways in macrophages, 
we transfected control siRNA or TRIM27 siRNA into U937 cells and infected with BCG stain for 0–48 h, fol-
lowed by the phosphorylation level detection of Iκ Bα , JNK, p38 and Erk. Immunoblot analysis data showed that 
knockdown of TRIM27 in U937 cells led to the suppression of JNK and p38 phosphorylation but increased Iκ 
Bα phosphorylation compared with wild-type (WT) U937 cells, especially at 48 h post-infection. Erk pathway 
was not obviously regulated by TRIM27 in infected U937 cells (Fig. 3c). Collectively, these results indicate that 
TRIM27 regulates the NF-κ B and JNK/p38 pathways during mycobacterial infection, which function could be 
antagonized by the secreted mycobacterial effector protein PtpA, independent of its phosphatase activity.
Figure 2. TRIM27 restricts the intracellular survival of mycobacteria. (a) The protein levels of TRIM27 were 
analyzed by immunoblot analysis in U937 cells transfected with luciferase siRNA (NC) or TRIM27 siRNA. 
(b,c) Survival of BCG (b) and M. smegmatis (c) in U937 cells infected with BCG or M. smegmatis at a MOI of 10 
for 0–48 h. Non-infected cells were used as a control. (d,e) The levels of TRIM27 were examined in U937 cells 
infected with BCG (d) or M. smegmatis (e) at a MOI of 10 for 0–24 h. Non-infected cells and cells treated with 
latex beads served as control groups. Data are shown as the means ± s.e.m. *P < 0.05 and **P < 0.01.
www.nature.com/scientificreports/
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Mtb PtpA antagonizes TRIM27-mediated cytokine production promotion and mycobacterial 
intracellular survival inhibition. Cytokines, as the products of the immune signaling activation, are essen-
tial in host defense against invading pathogens. Our data indicated that TRIM27 potentiates anti-mycobacterial 
responses through mediating innate immune signaling pathways, which may lead to production of a number 
of cytokines to activate the immune system. To determine which cytokines are modulated by TRIM27 during 
mycobacterial infection, we treated WT U937 or TRIM27-knockdown (KD) U937 or TRIM27-KD U937 cells 
complemented with RING domain deleted TRIM27 (TRIM27 Δ RING) cells with BCG for 0–48 h, and analyzed 
the transcription level of il1b and il8 by quantitative real-time PCR (Fig. 4a,b) and the protein level of IL-1β 
and IL8 secreted to the medium by Enzyme-linked immunosorbent assay (ELISA) (Supplementary Fig. 5a,b). 
Non-infected cells were used as a control. We found that knockdown of TRIM27 efficiently suppressed the 
Figure 3. TRIM27 promotes the activation of JNK and p38 pathways and suppresses NF-κB activation. 
(a,b) Luciferase assay of of AP-1 (a) and NF-κ B (b) activation in U937 cells. Cells were transfected with 
luciferase siRNA (NC siRNA) or TRIM27 siRNA or TRIM27 siRNA complemented with TRIM27 (Δ RING), 
and then were infected with WT BCG or BCG (Δ PtpA) or the BCG (Δ PtpA) complemented with PtpA D126A 
(Δ PtpA+ D126A) at a MOI of 10 for 24 h. (c) Immunoblot analysis of phosphorylated Iκ Bα , JNK, p38, Erk and 
GAPDH (loading control) in U937 cells transfected with luciferase siRNA (NC siRNA) or TRIM27 siRNA and 
infected with BCG at a MOI of 10 for 0–48 h. Non-infected cells served as a control group. Data are shown as the 
means ± s.e.m. *P < 0.05 and **P < 0.01.
www.nature.com/scientificreports/
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production of IL-1β and IL8 in BCG-infected macrophages since 2 h post-infection, and the complementation 
with TRIM27 Δ RING exhibited the same suppression effects (Fig. 4a,b; Supplementary Fig. 5a,b). Thus, TRIM27 
promotes the production of several cytokines (such as IL-1β and IL8) during mycobacterial infection, which 
depends on its RING domain. As with its antagonizing effects towards TRIM27-mediated regulation of the 
Figure 4. Mtb PtpA antagonizes TRIM27-promoted cytokine production and TRIM27-inhibited 
mycobacterial intracellular survival. (a,b) Quantitative PCR analysis of il1b mRNA (a) and il8 mRNA  
(b) in U937 cells. Cells were transfected with NC siRNA or TRIM27 siRNA or TRIM27 siRNA complemented 
with TRIM27 (Δ RING), and then were infected with WT BCG or BCGΔ PtpA or BCG (Δ PtpA+ D126A) at 
a MOI of 10 for 0–48 h. Non-infected cells served as a control group. Analysis of each gene was normalized to 
GAPDH. (c) Survival of BCG in U937 cells treated as in (a,b). Data are shown as the means ± s.e.m. *P < 0.05 
and **P < 0.01.
www.nature.com/scientificreports/
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NF-κ B and JNK/p38 pathways, PtpA also counteracted the TRIM27-promoted production of IL-1β and IL8 dur-
ing mycobacterial infection in a phosphatase activity-independent manner (Fig. 4a,b; Supplementary Fig. 5a,b). 
Furthermore, TRIM27 could better inhibit the intracellular survival of mycobacteria in the absence of PtpA, and 
both WT BCG and the PtpA phosphatase-inactive mutant (D126A) strain could counteract this inhibitory effect, 
though the overall CFUs of the PtpA D126A mutant strain were much lower than that of the WT BCG (Fig. 4c). 
Together these data demonstrate that PtpA plays a critical role in counteracting the restriction effects of TRIM27 
against mycobacterial infection in a phosphatase activity-independent manner.
Mtb PtpA antagonizes TRIM27-promoted macrophage apoptosis during mycobacterial infection. 
In response to bacterial infection, programmed cell death, such as apoptosis, is induced as host innate immune 
responses to eliminate pathogens at the early stage of infection. Previous reports suggested that TRIM27 sup-
presses NF-κ B activation32, and it can also ubiquitinate the ubiquitin-specific protease USP7, which deubiquit-
inates receptor-interacting protein1 (RIP1), leading to the promotion of cell apoptosis28. However, no evidence 
exists to indicate whether TRIM27 plays a role in the regulation of macrophage apoptosis during mycobacterial 
infection. Therefore, we performed immunoblot analysis to examine the level of cleaved caspase 3, a marker 
of apoptosis, in WT U937, TRIM27-KD U937 and TRIM27-KD U937 complemented with TRIM27 (Δ RING) 
cells infected with BCG for 0–48 h. Non-infected cells were used as a control. We observed a much higher level 
of cleaved caspase 3 in WT U937 cells than that in TRIM27-KD U937 cells or TRIM27 (Δ RING)-expressing 
U937 cells, especially at 48 h post-infection (Fig. 5a). Again, the effects of TRIM27-promoted cell apoptosis were 
more obvious during mycobacterial infection in the absence of PtpA, and the BCG strain expressing the PtpA 
D126A mutant had the same antagonizing effects as the WT BCG (Fig. 5a). Consistently, flow cytometry analysis 
data showed that the number of the early and late apoptosis cells significantly reduced in TRIM27-KD U937 
cells and TRIM27 (Δ RING)-expressing U937 cells compared with that in WT U937 cells at 24 h post- infec-
tion (Fig. 5b). Thus, TRIM27 plays an important role in promoting macrophage apoptosis during mycobacterial 
infection, which function is also dependent on its RING domain and antagonized by Mtb PtpA in a phosphatase 
activity-independent manner.
Global profiling of TRIM27-interacting proteins of Mtb. As described above, after infection 
of WT U937 cells, the CFUs of M. smegmatis markedly reduced and less than 10% bacteria survived at 48 h 
post-infection (Fig. 2c). In contrast, the CFUs of BCG began to increase since 8 h post-infection and reached its 
highest level at 48 h post-infection (Fig. 2b). This phenomenon, together with the observation that PtpA might 
antagonize the TRIM27-regulated immune-inflammatory responses and cell apoptosis during mycobacterial 
infection, prompted us to surmise that there might be certain effector proteins (which include but are not limited 
to PtpA) from Mtb which are able to interact with TRIM27 and antagonize its function during infection. We 
thus adopted the recently developed MTB Proteome Microarray to identify TRIM27-interacting Mtb proteins. 
The microarray contains more than 4,000 Mtb proteins. Purified GST and GST-TRIM27 were used to probe the 
microarray separately (Supplementary Fig. 6a). Using the stringent criteria described in Methods, we identified 
321 candidate TRIM27-interacting proteins (Supplementary Dataset 1), 29 of which are known as secreted pro-
teins (Supplementary Dataset 2). Six positive secreted proteins with the strongest interactions (calling score > 5) 
are shown in Supplementary Fig. 6b. All candidate TRIM27-interacting Mtb proteins and secreted proteins were 
analyzed respectively using STRING (Fig. 6a,b). The functional associations among these proteins were further 
analyzed using Cytoscape plugin ClueGO to decipher functionally grouped gene ontology (GO) and pathway 
annotation (Supplementary Fig. 7 and Supplementary Dataset 3). These TRIM27-interacting proteins were 
mainly involved in the metabolism (such as AtpC, HisG and FabG)33–35, stress reaction (such as Rv2026c) and 
intercellular survival (such as LpcC, PtpA, CysK1 and Pks16)36,37 of Mtb. As expected, Mtb PtpA was among the 
secreted proteins showing the strongest interaction with TRIM27 (Fig. 6b). These results suggest that TRIM27 
functions as an important restriction factor regulating the intracellular survival and replication of mycobacteria, 
the functions of which might be counteracted by certain Mtb secreted effector proteins such as PtpA during 
mycobacterial infection.
Discussion
Eukaryotic organisms have been exposed to pathogens for millions of years. This process has driven the devel-
opment of immune responses against invading pathogens. Some proteins called “restriction factors” are evolved 
to provide considerable resistance to pathogen infection. Previous studies have identified many virus restric-
tion factors, such as SAMHD1 and TRIM family members8,12,38, but few studies have reported restriction factors 
for bacteria pathogens, especially for Mtb, a leading cause of death in a global scale. In this study, we reveal 
that TRIM27 functions as a potential restriction factor which suppresses the intracellular survival of mycobac-
teria by enhancing host immune-inflammatory responses mediated by JNK/p38 pathways in an E3 ubiquitin 
ligase activity-dependent manner. Though TRIM proteins have been demonstrated as the key components of 
host antiviral innate immunity10, this is the first report demonstrating that TRIM27, another member from the 
TRIM protein family, could be added to the list of the increasing host restriction factors which plays important 
immune-regulatory roles during mycobacterial infection, and it might restrict other bacterial and viral pathogens 
as well.
To resist clearance by host immune defenses, pathogens have also evolved numerous countermeasures to 
escape host immunity. One of the most important strategies adopted by the bacterial pathogens is to produce 
various effector proteins to perturb host immune responses by targeting the key components of the innate 
immune system1. Mtb is known to be capable of persisting in host macrophage cells for a long time by producing 
various effector proteins to interfere with host signaling pathways. The main effector proteins of Mtb include 
11 eukaryotic-like serine/threonine protein kinases (PknA-PknL), 2 protein tyrosine phosphatases (PtpA and 
www.nature.com/scientificreports/
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Figure 5. Mtb PtpA antagonizes TRIM27-promoted cell apoptosis. (a) Immunoblot analysis of cleaved 
caspase 3 in U937 cells. Cells were transfected with NC or TRIM27 siRNA or TRIM27 siRNA complemented 
with TRIM27 (Δ RING), and were then infected with WT BCG or BCGΔ PtpA or BCG (Δ PtpA+ D126A) stain 
at a MOI of 10 for 0–48 h. Non-infected cells served as a control group. GAPDH was used as a loading control. 
(b) U937 cells were treated as in a and were infected with BCG at a MOI of 10. After 24 h, the cells were stained 
with PI and annexin V, followed by flow cytometry analysis (top) and statistical analysis (bottom). Data are 
shown as the means ± s.e.m. *P < 0.05 and **P < 0.01.
www.nature.com/scientificreports/
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PtpB), and the newly identified protein tyrosine kinase (PtkA), etc.39. We previously reported that Mtb tyros-
ine phosphatase PtpA, an important secreted effector protein required for intracellular survival of Mtb, inhibits 
innate immune signaling pathways and phagosome maturation by coopting host ubiquitin system16. In this study, 
Figure 6. TRIM27-interacting Mtb proteins visualized by Cytoscape. (a) TRIM27-interacting total Mtb 
proteins visualized by Cytoscape with fold change data incorporated (red = high fold change; green = low 
fold change). (b) TRIM27-interacting secreted Mtb proteins visualized by Cytoscape with fold change data 
incorporated (red: large fold change; green: small fold change).
www.nature.com/scientificreports/
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we revealed novel immune-regulatory mechanisms of Mtb PtpA. PtpA not only can directly dephosphorylate 
phosphor-JNK and p38 as we previously reported, but also can interacts with TRIM27 and counteracts its restric-
tion effects towards mycobacterial infection through regulating JNK/p38/NF-κ B pathways and cell apoptosis. 
Since Mtb PtpA is delivered into macrophages during infection and its amino acid sequence is 37% identical to 
that of the human low-molecular-weight phosphotyrosine phosphatase HCPTPA, several previous studies have 
made efforts to identify the host substrates of Mtb PtpA. So far, several confirmed (such as VPS33B, GSK3a, JNK 
and p38) and some more potential substrates of PtpA have been identified14,16,20,31. In this study, we also sought to 
determine whether TRIM27 is a substrate of PtpA, and our data denied this possibility. Since our data indicated 
that the secreted PtpA interacts with TRIM27 in macrophages during mycobacterial infection, and both WT Mtb 
PtpA and its D126A mutant interact with the RING domain of TRIM27, we thus propose that PtpA blocks the E3 
ubiquitin ligase activity of TRIM27 by binding competitively to its E3 ubiquitin activity-associated RING domain, 
thus leading to the antagonization of the TRIM27-mediated host innate immune signaling and cell apoptosis. 
Taken together, though the phosphatase activity of PtpA is critical in suppressing the activation of Jnk and p38 
and the ensuing host innate immune responses16, it is not required for the PtpA-mediated antagonizing effects of 
TRIM27 activity during mycobacterial infection.
After infection by mycobacteria, the protein levels of TRIM27 in macrophages significantly increased since 
2 h post-infection and reached its highest level at 8 h post-infection, followed by a sharp decrease in later time 
points. Concurrently, the CFUs decreased from 2 h post-infection of either BCG or M. smegmatis, but differences 
in the CFUs dynamics between BCG and M. smegmatis were observed during the later time points: while the 
CFUs of the M. smegmatis decreased consistently, the CFUs of the BCG increased after 24 h post-infection. These 
findings suggested that the protein levels of TRIM27 are highly regulated according to the existing CFUs of the 
pathogens to meet its function in restricting the intracellular survival of the pathogens. On the contrary, to pro-
mote their intracellular survival, certain intracellular pathogens such as the slow-growing and diseases-causing 
Mycobacterium tuberculosis complex (MTBC) members of mycobacteria such as BCG and Mtb are able to secrete 
effector proteins such as PtpA to antagonize the restriction effects of host factors such as TRIM27 at later time 
points post-infection. Therefore, our findings highlight the evolutionary dynamics of toggling between a restric-
tion factor and its pathogen antagonist during mycobacterial infection.
In conclusion, our study demonstrated that on the one hand, TRIM27 functions as a potential restriction 
factor for mycobacteria; and on the other hand, pathogens such as BCG and Mtb have evolved to antagonize the 
restriction functions of TRIM27 through secreting immune-regulatory effector proteins such as PtpA. Our study 
could have a fundamental impact on promoting efforts in the development of novel anti-TB therapies based on 
pathogen-host interfaces (such as the TRIM27-PtpA interaction interfaces).
Methods
Bacterial strains, mammalian cell lines and antibodies. E. coli DH5α and BL21 were grown in flasks 
using LB medium. M. smegmatis mc2 155 and M. bovis BCG (Pasteur) strains were grown in Middlebrook 7H9 
broth (7H9) supplemented with 10% oleic acid–albumin–dextrose–catalase (OADC) and 0.05% Tween-80 
(Sigma), or on Middlebrook 7H10 agar (BD) supplemented with 10% OADC. HEK293T (ATCC CRL-3216) and 
the human monocytic cell line U937 cells (ATCC CRL-1593.2) were obtained from the American Type Culture 
Collection (ATCC). HEK293T cells were maintained in Dulbecco’s modified Eagle’s medium (Gibco) with 10% 
fetal bovine serum (FBS), and U937 cells were maintained in RPMI 1640 medium with 10% FBS. For infec-
tion, U937 cells were cultured for 2 d in culture medium supplemented with 10 ng/ml of Phorbol 12-myristate 
13-acetate (PMA, Sigma). The following antibodies were used in this study: anti-Myc (sc-40, Santa Cruz), anti-
Flag (F3165, Sigma), anti-β -actin (A2228, Sigma), anti-phospho-Jnk (sc-81502, Santa Cruz), anti-phospho-Iκ Bα 
(sc-101713, Santa Cruz), anti-phospho-p38 (9211S, Cell Signaling), anti-phospho-Erk (9100S, Cell Signaling), 
anti-phospho-tyrosine (Sigma). In Supplementary Table 1, we list detailed information on strains, plasmids and 
oligonucleotides used in this study.
Immunoblot analysis and immunoprecipitation. For immunoblot analysis, cells were washed twice 
with ice-cold PBS, scraped, pelleted and lysed in the cell lysis buffer for Western and IP (P0013, Beyotime). After 
incubation for 10 min on ice, cell lysates were centrifuged at 14,000 rpm for 10 min at 4 °C. Protein concentration 
of lysates was determined by BCA protein assay kit (P0010, Beyotime) and the lysates were adjusted with cell lysis 
buffer. Proteins were separated by 8–15% SDS-PAGE transferred to PVDF membrane (Millipore). The blots were 
blocked for 1 h at room temperature with 5% non-fat dry milk in TBST (TBS and 0.05% Tween-20). Incubation 
with specific primary antibodies was performed in blocking buffer overnight at 4 °C. Goat anti-mouse IgG or 
goat anti-rabbit IgG conjugated to HRP was used as secondary antibody. The blots were developed by Immobilon 
Western Chemiluminescent HRP Substrate (WBKLS0500, Millipore) according to the manufacturer’s instruc-
tions. For immunoprecipitation, transfected cells were lysed in the Western and IP buffer (P0013, Beyotime). Cell 
lysates were incubated with Flag M2 beads (A2220, Sigma) or anti-Myc (9E10) beads (sc-40AC, Santa Cruz) and 
were analyzed by SDS-PAGE and blotted with indicated antibodies.
RNA interference. U937 cells were transfected with 50 nM small interfering RNA with Lipofectamine™ 
RNAiMAX (13778, Invitrogen) according to the manufacturer’s instructions. Twelfth hours after the first transfec-
tion, cells were re-transfected as above, and the cells were incubated for a further 24 h before harvest for infection 
and analysis. The small interfering RNA sequences were as follows: TRIM27 siRNA, forward - ggagaaaatccaa-
gaattauu, reverse - uaauucuuggauuuucuccuu; Luciferase siRNA (NC siRNA), forward - uucuccgaacgugucacguuu, 
reverse - acgugacacguucggagaauu.
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Real-time PCR. Total RNA was extracted from cells using TRIzol reagent (Invitrogen). The RNA was then 
used in a reverse transcription reaction using the RT-kit (R1012, Dongsheng Biotech). cDNA was then ana-
lyzed by quantitative PCR with KAPA SYBR FAST qPCR Kit (KAPA Biosystems) on ABI 7300 system (Applied 
Biosystems). Assays were performed in triplicates and three independent experiments were performed. Data are 
presented as mean values ± s.e.m. The following primer sequences (5′ -3′ ) were used: tnf, forward - cctctctcttaat-
cagccctctg, reverse - gaggacctgggagtagatgag; il1b, forward - atgatggcttattacagtggcaa, reverse- gtcggagattcgtagct-
gga; gapdh, forward - ggagcgagatccctccaaaat, reverse - ggctgttgtcatacttctcatgg.
ELISA quantification of cytokines. U937 cells (2 × 105/well) were cultured in a 6-well plate for 1 d in 
culture medium supplemented with PMA. Levels of IL-1β in the collected medium were measured using ELISA 
quantification kit (KHC0011, Invitrogen) according to the manufacturer’s instructions. Assays were performed 
in triplicates and three independent experiments were performed. Data are presented as mean values ± s.e.m.
Yeast two-hybrid assay. Yeast two-hybrid assay was performed using the Matchmaker Two-Hybrid 
System (Clontech) by following the manufacturer’s instructions. The mouse cDNA library Mate & Plate Library 
(CATALOG No. 630478; Clontech Laboratories, Inc.) was used to identify host interaction proteins of Mtb 
PtpA with yeast two-hybrid assay. Mtb PtpA gene was subcloned into the plasmid pGBKT7 as the bait plas-
mid. Saccharomyces cerevisiae AH109 cells were cotransduced with the bait plasmids and the prey plasmids 
by the lithium acetate method. To test the interactions between proteins, the transformants were streaked onto 
low-stringency (lacking leucine and tryptophan) and high-stringency (lacking adenine, histidine, leucine and 
tryptophan) selection plates.
Luciferase reporter assay. Luciferase reporter assay was performed using the Promega luciferase reporter 
system. To measure NF-κ B activation, HEK293T cells were co-transfected with 1 μ g of pNF-κ B-Luc and 50 ng of 
pRL-TK with or without 1 μ g of TRIM27 plasmid. 24 h later, cells were treated with 40 ng/ml of TNF (Invitrogen) 
for 6 h. For JNK and p38 pathways activation, HEK293T cells were co-transfected with 0.3 μ g of pFA-cJun, 0.9 μ g 
of Gal4-luc, 50 ng of pRL-TK and 0.5 μ g of RacL61 with or without 1 μ g of TRIM27 plasmid. The fold induction 
was calculated as (relative light units stimulated)/(relative light units unstimulated).
Immunouorescence confocal microscopy. U937 cells were seeded at 4 × 106 cells/well in a 6-well plate 
and differentiated with 10 ng/ml PMA. After 24 h, cells were infected with BCG for 4 h at a MOI of 20 and washed 
three times, fixed in 4% paraformaldehyde, permeabilized with 0.5% Triton X-100 and blocked with BSA for 1 h, 
and labeled with antibodies against PtpA (prepared as described previously16) and TRIM27 (sc-47513, Santa 
cruz). Bacteria were stained with Alexa 350 carboxylic acid succinimidyl eater (A101678, Invitrogen). Confocal 
images were taken with a Leica SP8 confocal system and were processed with the Leica LAS AF Lite program.
Annexin V and propidium iodide (PI) assay using flow cytometry. U937 cells were differentiated 
with 10 ng/ml PMA. After 24 h, the cells were washed once and cultured in fresh RPMI-1640 medium for an addi-
tional 8 h before infection. The U937 cells were infected with mycobacterial strains at a multiplicity of infection 
(MOI) of 10:1. After 24 h incubation, the media were discarded, and washed twice with PBS, and resuspended in 
500 μ l of 1× binding buffer. Annexin V-propidium iodide (PI) was then added in accordance with the Annexin 
V-PI Apoptosis Detection Kit (C1062, Beyotime) protocol. Flow cytometry (BD FACSCalibur) was used for the 
quantification of apoptotic cells.
MTB Proteome Microarray assay. A total of 4262 proteins from MTB strains were spotted in dupli-
cate on polymer slides (microarray-TB-12, BCBio). MTB proteome microarrays were blocked for 1 h at room 
temperature with shaking in blocking buffer (3% BSA, 1 × TBST, and 0.1% Tween 20 [pH 7.4]). To identify 
TRIM27-interacting proteins, we probed the MTB proteome microarray with a biotinylated-TRIM27 (0.05 mg/ml). 
Biotinylated-BSA (0.05 mg/ml) was used as negative controls. After incubating overnight at 4 °C with shaking, 
arrays were washed three times with shaking in 1 × TBST and then probed with 3 ml Cy3-strepavadin (1 mg/mL 
in 1 × TBST buffer; Sigma-Aldrich) for 1 h at room temperature with shaking. After washing three times in 1 × TBST 
and once in ddH2O, arrays were dried and then scanned. The signal to noise ratio (SNR) of each protein was aver-
aged for the two duplicated spots on each microarray incubated with GST (SNR−) or GST-TRIM27 (SNR+). To 
identify which proteins had significantly higher SNRs in the microarray incubated with GST-TRIM27 than in the 
control microarray, calling score was defined as SNR+/SNR− and calculated for all the proteins. Cutoff values were 
set as calling score > 2 and SNR > 3 for TRIM27-interacting proteins.
Analysis of protein interaction networks. The protein interaction networks were analyzed using 
STRING 1040 and visualized using Cytoscape 3.3.041. The protein association network constructed by STRING 
was further analyzed using Cytoscape plugin ClueGO to decipher functionally grouped gene ontology and path-
way annotation. GO enrichment of the network data was carried out to detect significantly overrepresented 
GO in terms of their associated biological processes components. The P value was calculated with a two-sided 
minimal-likely-hood test on the hypergeometric distribution. The degree of connectivity between GO terms was 
calculated using kappa statistics. The calculated kappa score of ≥ 0.3 was used for defining functional groups.
Statistical analysis. The data in the graphs are expressed as the mean ± s.e.m. Two-tailed unpaired t-test 
with Welch’s correction was used for statistical analysis. Each value of *P < 0.05 or **P < 0.01 was considered to 
be statistically significant.
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